Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$0.98 $0.03 (3.05%) RKDA stock closing price Feb 22, 2017 (Closing)

The cash flow statement is one of the reports a publicly traded company like Arcadia Biosciences needs to disclose. This statement shows details about the cash generated and spent during a particular quarter, while the other two statements give details about Arcadia Biosciences profits and Arcadia Biosciences debt. Arcadia Biosciences had cash and cash equivalents of $16.57M at beginning of year and $23.97M at year end for 2015. Arcadia Biosciences cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Arcadia Biosciences had an outflow of $0.32M from operating activities, $38.76M inflow due to financing activities, and $44.77M spend due to investing activities for 2015. View details of Arcadia Biosciences cash flows for latest & last ten financial years.

show more
Fiscal year is Jan - Dec. 2015 2014 2013
Arcadia Biosciences Net Income Cash Flow
-17.95M-18.33M-13.19M
Depreciation Depletion Amortization Cash-Flow0.37M0.35M0.39M
Net Increase (Decrease) in Assets Liabilities-0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations---
Other Adjustments Net2.52M4.53M3.2M
Arcadia Biosciences Net Cash from (used by) Operating Activities
-15.1M-14.78M-9.74M
Increase (Decrease) in Prop Plant And Equipment-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires--1.45M-0.5M
Increase (Decrease) in Investments-46.21M--
Other Cash Inflow (Outflow) from Investment Activities---
Arcadia Biosciences Net Cash from (used by) Invesment Activities
-46.36M-1.59M-0.6M
Issuance (Purchase) of Equity Shares68.58M32.86M0.01M
Issuance (Repayment) of Debt Securities10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings---
Payment of Dividends & Other Cash Distributions---
Other Cash from (used by) Financing Activities
Arcadia Biosciences Net Cash from (used by) Financing Activities
68.87M30.11M7.83M
Effect of Exchange Rate Changes on Cash---
Arcadia Biosciences Net Change in Cash & Cash Equivalents
7.4M13.73M-2.51M
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M
Cash & Equivalents at Year End23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.
Get Cash flow for another ticker

Arcadia Biosciences stock price history provides insight into historical stock price fluctuations, and Arcadia Biosciences stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:
  • Arcadia Biosciences saw a decrease in Net Change in Cash and Cash Equivalents from $13.73M in 2014 to $7.4M in 2015. Apart from the Arcadia Biosciences stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Arcadia Biosciences reported a negative operating cash flow of $-15.1M for 2015 and has seen a decrease from the previous year. Operating cash flow or working capital comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies (typically most tech companies) spend heavily  on investing activities and this figure was negative at $-46.36M for RKDA stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Arcadia Biosciences earned $38.76M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.
.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin
-3.67